These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23715783)

  • 1. Remnant nephron physiology and the progression of chronic kidney disease.
    Schnaper HW
    Pediatr Nephrol; 2014 Feb; 29(2):193-202. PubMed ID: 23715783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephron overload as a therapeutic target to maximize kidney lifespan.
    Luyckx VA; Rule AD; Tuttle KR; Delanaye P; Liapis H; Gandjour A; Romagnani P; Anders HJ
    Nat Rev Nephrol; 2022 Mar; 18(3):171-183. PubMed ID: 34880459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing Protein Permeability with Nephron Loss: Evidence for a Human Remnant Nephron Effect.
    Willows J; Odudu A; Logan I; Sheerin N; Tomson C; Ellam T
    Am J Nephrol; 2019; 50(2):152-159. PubMed ID: 31269482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways to nephron loss starting from glomerular diseases-insights from animal models.
    Kriz W; LeHir M
    Kidney Int; 2005 Feb; 67(2):404-19. PubMed ID: 15673288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephron number, hypertension, and CKD: physiological and genetic insight from humans and animal models.
    Wang X; Garrett MR
    Physiol Genomics; 2017 Mar; 49(3):180-192. PubMed ID: 28130427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathways of chronic kidney disease progression.
    Bienaimé F; Canaud G; El Karoui K; Gallazzini M; Terzi F
    Nephrol Ther; 2016 Apr; 12 Suppl 1():S35-8. PubMed ID: 26972095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical consequences of developmental programming of low nephron number.
    Luyckx VA; Brenner BM
    Anat Rec (Hoboken); 2020 Oct; 303(10):2613-2631. PubMed ID: 31587509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tubulointerstitial Pathophysiology of Progressive Kidney Disease.
    Schnaper HW
    Adv Chronic Kidney Dis; 2017 Mar; 24(2):107-116. PubMed ID: 28284376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephron mass as a risk factor for progression of renal disease.
    Brenner BM; Mackenzie HS
    Kidney Int Suppl; 1997 Dec; 63():S124-7. PubMed ID: 9407439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic renal insufficiency: 1) adaptation of nephron function in chronic renal insufficiency and 2) progression of chronic renal insufficiency].
    Savin M
    Srp Arh Celok Lek; 1998; 126(7-8):261-70. PubMed ID: 9863393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with a vicious cycle involving a low nephron number, hypertension and chronic kidney disease.
    Kanzaki G; Tsuboi N; Haruhara K; Koike K; Ogura M; Shimizu A; Yokoo T
    Hypertens Res; 2015 Oct; 38(10):633-41. PubMed ID: 26084263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
    J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte is the major culprit accounting for the progression of chronic renal disease.
    Kriz W
    Microsc Res Tech; 2002 May; 57(4):189-95. PubMed ID: 12012382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephron Deficiency and Predisposition to Renal Injury in a Novel One-Kidney Genetic Model.
    Wang X; Johnson AC; Williams JM; White T; Chade AR; Zhang J; Liu R; Roman RJ; Lee JW; Kyle PB; Solberg-Woods L; Garrett MR
    J Am Soc Nephrol; 2015 Jul; 26(7):1634-46. PubMed ID: 25349207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Towards understanding chronic kidney disease].
    Vergnaud P; Cohen C; Isnard P
    Med Sci (Paris); 2023 Mar; 39(3):265-270. PubMed ID: 36943124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Nephron Glomerular Filtration Rate in Healthy Adults.
    Denic A; Mathew J; Lerman LO; Lieske JC; Larson JJ; Alexander MP; Poggio E; Glassock RJ; Rule AD
    N Engl J Med; 2017 Jun; 376(24):2349-2357. PubMed ID: 28614683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spread of glomerular to tubulointerstitial disease with a focus on proteinuria.
    Theilig F
    Ann Anat; 2010 May; 192(3):125-32. PubMed ID: 20400279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-1α activation improves renal oxygenation and mitochondrial function in early chronic kidney disease.
    Thomas JL; Pham H; Li Y; Hall E; Perkins GA; Ali SS; Patel HH; Singh P
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F282-F290. PubMed ID: 28331062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights on glomerular hyperfiltration: a Japanese autopsy study.
    Kanzaki G; Puelles VG; Cullen-McEwen LA; Hoy WE; Okabayashi Y; Tsuboi N; Shimizu A; Denton KM; Hughson MD; Yokoo T; Bertram JF
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss.
    Cachat F; Lange-Sperandio B; Chang AY; Kiley SC; Thornhill BA; Forbes MS; Chevalier RL
    Kidney Int; 2003 Feb; 63(2):564-75. PubMed ID: 12631121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.